The non-genomic actions of vitamin D

Nutrients

Volumn 8, Issue 3, 2016, Pages

  Hii, Charles S ^a,b   Ferrante, Antonio ^a,b,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

MAP kinases; Protein kinase C; Signalling molecules; Vitamin D; Vitamin D receptor; Vitamin D response element

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CAVEOLIN 1; CYTOKINE; PHOSPHOLIPASE A2; PROTEIN KINASE C; VITAMIN D; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN;

BONE REMODELING; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION; AGONISTS; ANIMAL; DIETARY SUPPLEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY;

ANIMALS; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84960130021     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8030135     Document Type: Review

References (62)

1. Gröber, U.; Reichrath, J.; Holick, M.F. Live longer with vitamin D? Nutrients 2015, 7, 1871–1880.
2. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266–281.
3. Mazahery, H.; von Hurst, P.R. Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation. Nutrients 2015, 7, 5111–5142.
4. Veugelers, P.J.; Ekwaru, J.P. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients 2014, 6, 4472–4475.
5. Heaney, R.; Garland, C.; Baggerly, C.; French, C.; Gorham, E. Letter to Veugelers, P.J. and Ekwaru, J.P. A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients 2014, 6, 4472–4475, doi: 10.3390/nu6104472. Nutrients 2015, 7, 1688–1690
6. Paller, C.J.; Kanaan, Y.M.; Beyene, D.A.; Naab, T.J.; Copeland, R.L.; Tsai, H.L.; Kanarek, N.F.; Hudson, T.S. Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status. Prostate 2015, 75, 1376–1383.
7. Jones, G.; Strugnell, S.A.; DeLuca, H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78, 1193–1231.
8. Christakos, S.; Pandya, M.R.; Yang, W. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochem. J. 1996, 316, 361–371.
9. Hewison, M.; O’Riordan, J.L.H. Immuno modulatory and cell differentiation effects of vitamin D. In Vitamin D; Feldman, D., Glorieux, F.H., Pike, J.W., Eds.; Academic Press: San Diego, CA, USA, 1997; pp. 447–462
10. Issa, L.L.; Leong, G.M.; Eisman, J.A. Molecular mechanism of vitamin D receptor action. Inflamm. Res. 1998, 47, 451–475.
11. Omdahl, J.L.; May, B.K. The 25-hydroxyvitamin D 24-hydroxylase. In Vitamin D; Feldman, D., Glorieux, F.H., Pike, J.W., Eds.; Academic Press: San Diego, CA, USA, 1997; pp. 69–85
12. Fleet, J.C. Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: What are they and what do they mean? J. Nutr. 2004, 134, 3215–3218.
13. Doroudi, M.; Schwartz, Z.; Boyan, B. D. Membrane-mediatedactionsof1,25-dihydroxyvitaminD3: Areview of the roles of phospholipase A2 activating protein and Ca(2+)/calmodulin-dependent protein kinase II. J. Steroid Biochem. Mol. Biol. 2015, 147, 81–84.
14. Dwivedi, P.P.; Hii, C.S.; Ferrante, A.; Tan, J.; Der, C.J.; Omdahl, J.L.; Morris, H.A.; May, B.K. Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. J. Biol. Chem. 2002, 277, 29643–29653.
15. Nutchey, B.K.; Kaplan, J.S.; Dwivedi, P.P.; Omdahl, J.L.; Ferrante, A.; May, B.K.; Hii, C.S. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: Role of MAP kinase activities and identification of an important transcription factor binding site. Biochem. J. 2005, 389, 753–762.
16. Dwivedi, P.P.; Gao, X.H.; Tan, J.C.; Evdokiou, A.; Ferrante, A.; Morris, H.A.; May, B.K.; Hii, C.S. A role for the phosphatidylinositol 3-kinase—Protein kinase C zeta—Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25-hydroxyvitamin D3 24-hydroxylase gene in human kidney cells. Cell. Signal. 2010, 22, 543–552.
17. Norman, A.W. Minireview: Vitamin Dreceptor: New assignments for anal ready busy receptor. Endocrinology 2006, 147, 5542–5548.
18. Dormanen, M.C.; Bishop, J.E.; Hammond, M.W.; Odamura, W.H.; Nemere, I.; Norman, A.W. Nonnuclear effects of the steroid hormone 1 alpha, 25(OH)2-vitamin D3: Analogs are able to functionally differentiate between nuclear and membrane receptors. Biochem. Biophys. Res. Commun. 1994, 201, 394–401.
19. Nemere, I.; Dormanen, M.C.; Hammond, M.W.; Okamura, W.H.; Norman, A.W. Identification of a specific binding protein for 1,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 1994, 269, 23750–23756.
20. Huhtakangas, J.A.; Olivera, C.J.; Bishop, J.E.; Zanello, L.P.; Norman, A.W. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro. Mol. Endocrinol. 2004, 18, 2660–2671.
21. Chen, J.; Doroudi, M.; Cheung, J.; Grozier, A.L.; Schwartz, Z.; Boyan, B.D. PlasmamembranePdia3andVDR interact to elicit rapid responses to 1α,25(OH)(2)D(3). Cell. Signal. 2013, 25, 2362–2373.
22. Boyan, B.D.; Sylvia, V.L.; McKinney, N.; Schwartz, Z. Membrane actions of vitamin D metabolites 1α,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice. J. Cell. Biochem. 2003, 90, 1207–1223.
23. Yamauchi, J.; Sekiguchi, M.; Shirai, T.; Ishimi, Y. Vitamin D receptor is not essential for extracellular signal-relatedkinasephosphorylationbyvitaminD(3)inhumanCaco-2/TC7cells. Biosci.Biotechnol.Biochem. 2012, 76, 1588–1590.
24. Buitrago, C.; Pardo, V.G.; Boland, R. Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells. J. Steroid Biochem. Mol. Biol. 2013, 136, 125–130.
25. Antal, C.E.; Newton, A.C. Tuning the signalling output of protein kinase C. Biochem. Soc. Trans. 2014, 42, 1477–1483.
26. Sequeira, V.B.; Rybchyn, M.S.; Tongkao-On, W.; Gordon-Thomson, C.; Malloy, P.J.; Nemere, I.; Norman, A.W.; Reeve, V.E.; Halliday, G.M.; Feldman, D et al. The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3. Mol. Endocrinol. 2012, 26, 574–582.
27. Tan, J.; Dwivedi, P.P.; Anderson, P.; Nutchey, B.K.; O’Loughlin, P.; Morris, H.A.; May, B.K.; Ferrante, A.; Hii, C.S. Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: Implications in anticancer activity. Mol. Cancer Ther. 2007, 6, 3131–3138.
28. Wang, X.; Pesakhov, S.; Harrison, J.S.; Danilenko, M.; Studzinski, G.P. ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells. J. Cell. Physiol. 2014, 229, 856–867.
29. Schwartz, Z.; Ehland, H.; Sylvia, V.L.; Larsson, D.; Hardin, R.R.; Bingham, V.; Lopez, D.; Dean, D.D.; Boyan, B.D. 1alpha,25-dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase. Endocrinology 2002, 143, 2775–2786.
30. Cui, M.; Zhao, Y.; Hance, K.W.; Shao, A.; Wood, R.J.; Fleet, J.C. Effects of MAPK signalling on 1,25dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2. J. Cell. Physiol. 2009, 21, 132–142.
31. Jiang, Y.; Fleet, J.C. Phorbol esters enhance 1α,25-dihydroxyvitamin D3-regulated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) gene expression through ERK-mediated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells. Mol. Cell. Endocrinol. 2012, 361, 31–39.
32. Simboli-Campbell, M.; Gagnon, A.; Franks, D.J.; Welsh, J. 1,25-dihydroxyvitamin D3 translocates protein kinase C beta to nucleus and enhances plasma membrane association of protein kinase C alpha in renal epithelial cells. J. Biol. Chem. 1994, 269, 3257–3264.
33. Chen, Y.; Zhang, J.; Ge, X.; Du, J.; Deb, D.K.; Li, Y.C. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J. Biol. Chem. 2013, 288, 19450–19458.
34. Lange, C.M.; Gouttenoire, J.; Duong, F.H.; Morikawa, K.; Heim, M.H.; Moradpour, D. Vitamin D receptor and Jak-STAT signalling crosstalk results in calcitriol-mediated increase of hepatocellularresponse to IFN-α. J. Immunol. 2014, 192, 6037–6044.
35. Wei, R.; Christakos, S. Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D. Nutrients 2015, 7, 8251–8260.
36. Li, Q.P.; Qi, X.; Pramanik, R.; Pohl, N.M.; Loesch, M.; Chen, G. Stress-induced c-Jun-dependent Vitamin D receptor (VDR) activation dissects the non-classical VDR pathway from the classical VDR activity. J. Biol. Chem. 2007, 282, 1544–1551.
37. Pálmer, H.G.; González-Sancho, J.M.; Espada, J.; Berciano, M.T.; Puig, I.; Baulida, J.; Quintanilla, M.; Cano, A.; de Herreros, A.G.; Lafarga, M. et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell. Biol. 2001, 154, 369–387.
38. Yuan, W.; Pan, W.; Kong, J.; Zheng, W.; Szeto, F.L.; Wong, K.E.; Cohen, R.; Klopot, A.; Zhang, Z.; Li, Y.C. 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP AMP response element in the renin gene promoter. J. Biol. Chem. 2007, 282, 29821–29830.
39. Ding, C.; Wilding, J.P.; Bing, C. 1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes. PLoS ONE 2013, 24, e61707.
40. Chen, Y.; Kong, J.; Sun, T.; Li, G.; Szeto, F.L.; Liu, W.; Deb, D.K.; Wang, Y.; Zhao, Q.; Thadhani, R. et al. 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation. Arch. Biochem. Biophys. 2011, 507, 241–247.
41. Chen, Y.; Liu, W.; Sun, T.; Huang, Y.; Wang, Y.; Deb, D.K.; Yoon, D.; Kong, J.; Thadhani, R.; Li, Y.C. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signalling via targeting microRNA-155-SOCS1 in macrophages. J. Immunol. 2013, 190, 3687–3695.
42. Deb, D.K.; Chen, Y.; Zhang, Z.; Zhang, Y.; Szeto, F.L.; Wong, K.E.; Kong, J.; Li, Y.C. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-kappa B pathway. Am. J. Physiol. Ren. Physiol. 2009, 296, F1212–F1218.
43. D’Ambrosio, D.; Cippitelli, M.; Cocciolo, M.G.; Mazzeo, D.; Di Lucia, P.; Lang, R.; Sinigaglia, F.; Panina-Bordignon,P.InhibitionofIL-12productionby1,25-dihydroxyvitaminD3. InvolvementofNF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Investig. 1998, 101, 252–262.
44. Lange, C.M.; Bojunga, J.; Ramos-Lopez, E.; von Wagner, M.; Hassler, A.; Vermehren, J.; Herrmann, E.; Badenhoop, K.; Zeuzem, S.; Sarrazin, C. VitaminDdeficiencyandaCYP27B1–1260promoterpolymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J. Hepatol. 2011, 54, 887–893.
45. Gal-Tanamy, M.; Bachmetov, L.; Ravid, A.; Koren, R.; Erman, A.; Tur-Kaspa, R.; Zemel, R. Vitamin D: AninnateantiviralagentsuppressinghepatitisCvirusinhumanhepatocytes. Hepatology2011,54,1570–1579.
46. Matsumura, T.; Kato, T.; Sugiyama, N.; Tasaka-Fujita, M.; Murayama, A.; Masaki, T.; Wakita, T.; Imawari, M. 25-Hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology 2012, 56, 1231–1239.
47. Greiller, C.L.; Martineau, A.R. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015, 7, 4240–4270.
48. Petta, S.; Camma C.; Scazzone, C.; Tripodo, C.; Di Marco, V.; Bono, A.; Cabibi, D.; Licata, G.; Porcasi, R.; Marchesini, G et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010, 51, 1158–1167.
49. Kroner Jde, C.; Sommer, A.; Fabri, M. Vitamin D every day to keep the infection away? Nutrients 2015, 7, 4170–4188.
50. Chun, R.F.; Liu, P.T.; Modlin, R.L.; Adams, J.S.; Hewison, M. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis. Front. Physiol. 2014, 5, 151.
51. Peric, M.; Koglin, S.; Dombrowski, Y.; Gross, K.; Bradac, E.; Ruzicka, T.; Schauber, J. VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid. Mol. Immunol. 2009, 46, 3183–3187.
52. Yim, S.; Dhawan, P.; Ragunath, C.; Christakos, S.; Diamond, G. Induction of cathelicidin in normal and cf bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 2007, 6, 403–410.
53. Campbell, G.R.; Spector, S.A. Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy 2012, 8, 1523–1525.
54. Campbell, G.R.; Spector, S.A. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog. 2012, 8, e1003017.
55. Qi, X.; Tang, J.; Pramanik, R.; Schultz, R.M.; Shirasawa, S.; Sasazuki, T.; Han, J.; Chen, G. P38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor. J. Biol. Chem. 2004, 279, 22138–22144.
56. Qi, X.; Pramanik, R.; Wang, J.; Schultz, R.M.; Maitra, R.K.; Han, J.; DeLuca, H.F.; Chen, G. The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition. J. Biol. Chem. 2002, 277, 25884–25892.
57. Jiang, J.; Shi, D.; Zhou, X. Q.; Yin, L.; Feng, L.; Jiang, W.D.; Liu, Y.; Tang, L.; Wu, P.; Zhao, Y. Vitamin D inhibits lipopolysaccharide-induced inflammatory response potentially through the Toll-like receptor 4 signalling pathway in the intestine and enterocyteso fjuvenile Jiancarp(Cyprinuscarpiovar. Jian). Br. J.Nutr. 2015,114, 1560–1568.
58. Al-Rasheed, N.M.; Al-Rasheed, N.M.; Bassiouni, Y.A.; Hasan, I.H.; Al-Amin, M.A.; Al-Ajmi, H.N.; Mohamad,R.A.VitaminDattenuatespro-inflammatoryTNF-αcytokineexpressionbyinhibitingNF-κB/p65 signaling in hypertrophied rat hearts. J. Physiol. Biochem. 2015, 71, 289–299.
59. Choi, M.; Park, H.; Cho, S.; Lee, M. Vitamin D3 supplementation modulate sinflammatory responses from the muscle damage induced by high-intensity exercise in SD rats. Cytokine 2013, 63, 27–35.
60. Gao, L.; Cao, J.T.; Liang, Y.; Zhao, Y.C.; Lin, X.H.; Li, X.C.; Tan, Y.J.; Li, J.; Zhou, C.L.; Xu, H.Y et al. Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome. Endocrine 2015.
61. Devaraj, S.; Yun, J.M.; Duncan-Staley, C.R.; Jialal, I. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am. J. Clin. Pathol. 2011, 135, 429–433.
62. Lucas, R.M.; Gorman, S.; Geldenhuys, S.; Hart, P.H. Vitamin D and immunity. F1000Prime Rep. 2014, 6, 118.